Nonclinical safety evaluation of pabinafusp alfa, an anti-human transferrin receptor antibody and iduronate-2-sulfatase fusion protein, for the treatment of neuronopathic mucopolysaccharidosis type II
2021 · Molecular Genetics and Metabolism Reports · 20 citations
https://doi.org/10.1016/j.ymgmr.2021.100758